Blockchain Transaction Record
Straightening Teeth in Three Months Possible? New Science Says Yes.
Study results confirm significant acceleration of tooth movement thereby reducing tooth straightening time and showed that 60% of treated patients had perfectly straight teeth within 3 months. - Dr. Leslie Miller, Chief Medical Officer
Exclusively at Newsworthy.ai — Newsworthy registers every press release distributed through this service on the blockchain so that we can provide verification services and make features such as the self-hosting of press releases available to our customers. The blockchain provides an immutable record of the press releases issued by this service. Immutability gives readers the assurance that the news they are reading has not been altered from the source document that this service distributed. We have shifted the Source of Truth to the blockchain for added protection.
Moving the Source of Truth to the blockchain improves transparency and increases trust between organizations submitting news and readers.
Key Takeaways (TLDR)
- OrthodontiCell's study demonstrates a significant reduction in teeth straightening time and a 70% reduction in pain compared to traditional braces or aligners.
- The company's patented procedure uses a patient's own proteins to soften bone, allowing for more rapid teeth straightening.
- OrthodontiCell's technology shows promise in improving millions of lives by offering a faster and less painful solution for misaligned teeth.
| Blockchain | Details |
|---|---|
| Chain | polygon-main |
| Transaction ID | 0xb18aabb1ca96271d1a25319bc5910b6c68381c694da897eee240518c248750cd |
| Contract Address | 0x1bA402ec7dDc1FAC5E85071be256f16351dF9Bb5 |
| NWAI Digital Fingerprint | 914-aeaf1a7d1779226c7d7868ece720b89b |
| Registration Timestamp | 2023-12-28T19:48:20+00:00 |
Other Recent Blockchain Registered News for OrthodontiCell Inc
- OrthodontiCell Secures Capital to Complete Testing Supporting Planned U.S. Phase II Pivotal Study Salt Lake City, Utah (Newsworthy.ai) Thursday Oct 15, 2026 @ 3:00 AM PDT — OrthodontiCell, Inc. announced today it believes it has secured sufficient capital to complete all FDA requested tests to file an application to request permission to begin a planned Phase II multi-center Pivotal Clinical Study in the USA for its bioelectric protein expression platform technology for accelerating teeth straightening OrthodontiCel